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Abstract 
Cyclic peptides have recently emerged as promising modulators of 
challenging protein-protein interactions. Here we report on the 
design, synthesis and conformational behavior of a small library 
composed of C2 symmetric cyclic hexapeptides of type c(Xaa-D-
Pro-Yaa)2, where Xaa and Yaa are chosen from alanine, isoleucine, 
serine, glutamic acid, arginine and tryptophan due to the favorable 
properties of the side chains of these residues to recognize 
complex protein surfaces. We used a combination of nuclear 
magnetic resonance and molecular dynamic simulations to 
perform an extensive conformational analysis of a representative 
set of cyclic hexapeptides. Our results indicated that both the 
chemical nature and the chirality of the variable Xaa and Yaa 
positions play an important role in the cis/trans configuration of the 
Xaa-D-Pro bonds and in the conformational preferences of this 
family of peptides. This structural tuning can be exploited in design 
strategies seeking to optimize the binding efficiency and selectivity 
of cyclic hexapeptides towards protein surfaces. 
Introduction 
Macrocycles have found broad application in chemical biology, 
biotechnology and pharmaceutical research.[1] Over the last 
decade, particularly intense efforts have been channelled into 
the development of macrocycles and their use in the field of 
molecular recognition.[2] Nowadays, most synthetic 
compounds reported to interact with proteins are small 
molecules that bind to well-defined cavities on the protein 
structure.[3] More challenging, however, is the design of 
molecules with the ability to bind to the solvent-exposed protein 
surface and specifically recognize the large interfacial areas 
involved in protein-protein interactions, with the purpose of 
interfering in the functional activity of the target protein.[4] The 
growing appreciation that these complex protein-protein 
interfaces appear to be ‘undruggable’ by small ligands has 
coincided with renewed interest in macrocycles, and cyclic 
peptides in particular, as potential protein binders, based on 
the premise that these cyclic molecules may be more suited to 
mimic natural biorecognition processes.[5] 
Cyclic peptides have a number of advantages over their 
linear counterparts.[6] For example, they show improved 
resistance to proteolytic degradation by exopeptidases due to 
the lack of both amino and carboxyl termini. Moreover, protein 
recognition is a conformation-dependent process, and 
converting linear sequences into their cyclized form is a 
common approach to modulate the performance of peptide 
sequences. A classic and elegant example is the chemical 
development of Cilengitide, a cyclic pentapeptide (c(Arg-Gly-
Asp-D-Phe-Val)) that is selective for αv integrins and that was 
under investigation for the treatment of glioblastoma.[7] 
Research on a variety of linear and cyclic penta- and 
hexapeptides containing the tripeptide sequence RGD 
(arginine, glycine and aspartic acid) showed that cycles 
inducing distinct conformations of RGD sequences were able 
to recognize various integrin receptors.[8] These pioneering 
studies showed that the preorganization of the crucial side 
chains by cyclization significantly affects the functional activity 
of the amino acid sequences. Both the binding affinity and the 
selectivity of a recognition motif introduced into a cyclic peptide 
may increase when its bioactive conformation is included in the 
restrained conformational space of the cyclic molecule. In this 
case, cyclization reduces the entropic penalty of binding, 
thereby improving the binding interaction. However, cyclization 
often results in a significant decrease or even a total loss of 
activity.[9] This occurs when the bioactive conformation of the 
recognition motif is excluded from the conformational space of 
the constrained peptide. It is also possible that, although 
accessible in the restricted conformational ensemble of the 
cycle, the bioactive conformation of the peptide is scarcely 
populated. Cyclic peptides still have considerable backbone 
mobility, but usually display rugged conformational landscapes 
that include a number of energy local minima that may not be 
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uniformly sampled. Reaching some conformational states may 
involve the rare crossing of significant energy barriers. 
Therefore, the cyclic molecule would thermally fluctuate 
among a subset of states at a given temperature. These crucial 
considerations should not be overlooked in screening projects 
based on “ligand-oriented design” strategies. The chances of 
finding suitable protein ligands will depend on the availability 
of a robust synthetic approach to generate a variety of diverse 
molecules, combined with detailed knowledge of the 
conformational behavior of the molecules generated.  
Motivated by these observations, we sought to synthesize 
a small library of C2 symmetric cyclic hexapeptides of the type 
c(Xaa-D-Pro-Yaa)2 (Scheme 1 and Table S1). We 
hypothesized that this family of constrained cyclic peptides 
may have potential applications in the recognition of different 
types of protein surfaces. In fact, this library has recently 
demonstrated to be useful as a source of ligands able to 
recognize two completely unrelated proteins, such as the 
human vascular endothelial growth factor (VEGF)[10] and the 
bacterial OmpA. One OmpA inhibitor selected from this library 
was shown to prevent bacterial infection in an in vivo model.[11] 
 
Scheme 1. Structures of peptides 1-31. Peptides 29, 30 and 31 are the 
enantiomers of peptides 7, 17 and 18, respectively.  
Cyclic hexapeptides are known to stabilize distinct 
conformations by adopting turn-like structures, although 
predicting their structures de novo is a considerable 
challenge.[12] For this reason, we conducted an extensive 
conformational study combining nuclear magnetic resonance 
(NMR) spectroscopy and molecular dynamics (MD) 
simulations of a selected set of representative cyclic 
hexapeptides. The effect of the nature and/or chirality of the 
variable Xaa and Yaa positions on the configuration of the Xaa-
D-Pro bond and on the overall conformational behavior of this 
family of peptides is also described in detail in this study. 
Results and Discussion 
Design of the library of cyclic hexapeptides  
Here we aimed to synthesize a family of cyclic peptides with a 
preorganized structural scaffold that could optimally present a 
set of side chains selected for their favorable properties for 
protein surface recognition. We focused on C2 symmetric 
cyclic hexapeptides due to their straightforward synthesis 
and because they adopt conformations featured by two fused 
β-turn arrangements.[13] Initially, we synthesized a set of 
peptides of the type c(Xaa-D-Pro-Yaa)2 (Scheme 1, peptides 
1-15) including a D-amino acid to enhance the β-turn 
propensity.[14] Xaa and Yaa could be Trp, Arg, Glu, Ser, Ala 
and Ile. These residues were rationally selected from all 
proteinogenic amino acids on the basis of the physicochemical, 
synthetic and statistical parameters considered in our previous 
work.[15]  
Tryptophan was chosen because it is over-represented at 
protein interfaces and is found on many hot spots. Like lysine, 
arginine (pI = 10.76) displays a positive charge at physiological 
pH. However, significant differences in the hydration energy 
and hydrogen bonding potential of these cationic amino acids 
make arginine more favorable to establish inter-residue 
contacts. Alanine is a highly abundant residue in natural 
systems. Since it has a small lateral side chain, it can act as a 
spacer for various interaction sites on peptides. Glutamic acid 
(pI = 3.22) contributes to negative charges. Serine is a polar 
non-charged amino acid that outperforms threonine in solid-
phase peptide synthesis (SPPS). Finally, isoleucine is an 
aliphatic β-branched amino acid with a significantly bulky side 
chain. It has a higher presence in active sites than valine and 
leucine. Proline was selected as it is the only genetically 
encoded N-alkyl amino acid and it often participates in crucial 
hydrophobic-hydrophobic interactions. In addition, D-proline is 
known to act as a turn-inducing element to promote peptide 
cyclization.[16] 
 The initial library was then expanded to include new 
peptides (peptides 16-31) (Scheme 1 and Table S1) with the 
aim of studying the influence of the chemical nature and/or 
chirality of the Xaa and Yaa positions on the conformational 
behavior of this family of cyclic peptides. 
FULL PAPER    
 
 
 
 
 
Synthesis of the C2 symmetric cyclic hexapeptides  
Cyclic hexapeptides were synthesized following a standard 
solid-phase Fmoc/tBu peptide synthesis protocol using 2-
chlorotrityl chloride (CTC) resin (Scheme 2). To compensate 
for the lower reactivity of the secondary amine groups of the 
prolyl residues, HATU was chosen as coupling reagent. All linear 
peptides were then synthesized as H-Xaa-Pro-Yaa-Xaa-Pro-
Yaa-OH, with its respective residue chirality. To prove that no 
epimerization was taking place in the C-terminus of these 
peptides during the synthesis, all the corresponding C-terminus 
epimers for each peptide of the initial library were synthesized 
(Scheme S1). Peptide cyclization was performed in solution 
using PyBOP/DIEA as coupling reagent.  
 
Scheme 2. Synthetic scheme for cyclic hexapeptides 1-31, where R = Pro 
or D-Pro, and R1, R2 correspond to the amino acids described in Scheme 1. 
Reagents and conditions: a) Fmoc-AA-OH (0.7 mmol/g resin), DIPEA (10 
eq.), DCM, 35 min; b) MeOH (0.8 mL/g resin), 15 min; c) piperidine 20% in 
DMF (2 x 1 min, 1 x 10 min); d) Fmoc-AA-OH (3 eq.), DIPEA (6 eq.), DMF, 
35 min; e) Fmoc-AA-OH (6 eq.), DIPEA (12 eq.), DMF, 20 min; f) 1% TFA in 
DCM (5 x 30 s); g) PyAOP (2 eq.), DIPEA (6 eq.), DCM/DMF (9:1) 6-12 h; 
and h) TFA:TIS:H2O (95:2.5:2.5), 10 mL/g resin, 1.5 h. 
Conformational analysis of C2 symmetric cyclic hexapeptides  
Effect of the chemical nature of amino acids on the 
conformation of c(Xaa-D-Pro-Yaa)2 cyclic hexapeptides. A 
representative set of cyclic hexapeptides was selected 
(peptides 3, 6, 7, and 11) (Scheme 1) to conduct an NMR-
based conformational analysis in aqueous solution. These 
peptides were used to study the effects of the chemical nature 
(charged, polar, aromatic and β-branched) of the Pro-
preceding and Pro-following residues on the overall 
conformational behavior of this family of cyclic hexapeptides.  
The observation of three individual spin systems in the 
NMR spectra of all four peptides confirmed the C2 symmetric 
nature of these molecules (Figure S1). This observation is 
consistent with these peptides populating either a unique 
conformation or different states coexisting in fast equilibrium in 
the NMR timescale. A complete resonance assignment is 
provided in the Supporting Information (Table S2). The 
resemblance of structure-sensitive NMR parameters such as 
secondary chemical shifts, 3JNHHα values, temperature 
coefficients of amide protons (Table 1), and 1H-1H NOESY 
correlations indicated that the four peptides adopt a similar 
conformation in solution. The configuration of the Xaa-D-Pro 
bond was trans in these peptides, as indicated by the chemical 
shift differences between the 13Cβ and 13Cγ (ΔδCβγ) of the Pro 
residue, with values around 4 ppm (Table 1).[17] The 
observation of an intense Hα (Xaa) – Hδ (D-Pro) NOE cross-
peak in the corresponding NOESY spectra (Figure 1a) further 
confirmed the trans configuration of the Xaa-D-Pro bond in 
these four peptides.  
 
Figure 1. Expanded regions of the NOESY spectra of peptides 7 (a) and (b) 
and 3 (c) showing intra-residue cross-peaks between Hα proton of the Glu 
residues and the Hδ  protons of the D-Pro residues, which confirmed the trans 
conformation of the Xaa-Pro bonds (a); and between the resonances of the 
NH and the Hb protons of the Trp residues (b) and (c). For peptide 7, the 
upfield Hb1 (Trp) proton presents a more intense NOE crosspeak with the 
NH (Trp) amide proton than the corresponding downfield Hb2 (Trp) proton, 
thereby indicating the predominance of the gauche (-) rotamer. In peptide 3, 
both diastereotopic Hb (Trp) protons display NOE cross-peaks with the NH 
(Trp) amide proton of similar intensity, thus suggesting an averaged 
population between the gauche (-) and gauche (+) rotameric states.  
The NH amide protons of the Xaa and Yaa residues within 
this set of peptides exhibited a well-differentiated trend. 
Irrespective of the chemical nature of the amino acid, the NH of 
Xaa residues showed higher-field chemical shifts (Table S2) and 
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smaller temperature coefficient values (-ΔδNH/ΔT) than those of 
the Yaa residues (Table 1).  
The reduced temperature dependence of the Xaa amide 
protons, ranging from 1.0 ppb K-1 in peptide 11 (Xaa = Ser) 
to 4.5 ppb K-1 in peptide 3 (Xaa = Arg), indicates their 
involvement in intramolecular hydrogen bonds. In contrast, 
the NH protons of the Yaa residues showed large 
temperature coefficients (7.7 – 8.5 ppb K-1) characteristic of 
solvent-exposed backbone amides. The 3JNHHα values 
observed for these peptides were in the range 7.7 – 9.6 Hz, 
consistent with a β-like conformation (Table 1). All these 
results, combined with the detection of a strong Hα (D-Pro) – 
NH (Yaa) NOE cross-peak (Figure S2), is consistent with a 
symmetric backbone conformation containing two fused type 
II’ β-turns. Regarding side chain conformation, interestingly, 
the two methylene Hβ protons of the aromatic side chain in Trp-
containing peptides (3, 7 and 11) showed marked differential 
NMR behavior. Peptides 7 (c(Glu-D-Pro-Trp)2) and 11 (c(Ser-
D-Pro-Trp)2) presented a noticeable diastereotopic Hβ (Trp) 
splitting (3.48 and 3.22 ppm for peptide 7; and 3.49 and 3.22 
ppm for peptide 11) and a remarkable difference in 3JHαHβ (Trp) 
values (4.3 and 9.5 Hz for peptide 7; and 4.4 and 9.6 Hz for 
peptide 11) (Figure 2). The pronounced differences observed 
between diastereotopic Hβ (Trp) protons suggest that the 
aromatic side chain in these peptides is relatively fixed. Of the 
two Hβ (Trp) protons, the one with the largest 3JHαHβ (Trp) value 
(δHβ = 3.22 ppm) was also the one showing the most intense 
intra-residue NOE cross-peak with the amide NH (Trp) proton 
(Figure 1b). 
 
Figure 2. Partial 1H-NMR spectra of peptides 3, 7, 11, 17, 18 and 23 showing 
the differential NMR behavior of the diastereotopic methylene Hb (Trp) 
protons (underlined).   
This observation would suggest the predominance of the 
gauche (-) rotamer (Figure 1d). Most probably, the rotation of 
the Trp side chain is restricted by the presence of CH-π 
interactions between the aromatic ring and the Pro methylene 
groups.The spatial proximity of the Pro and Trp side chains is 
in agreement with the upfield shift of Hα (Pro) (4.21 ppm in both 
peptides) and Hβ (Pro) protons (1.93 and 1.44 ppm for peptide 
7; and 1.91 and 1.42 ppm for peptide 11),[18] when compared 
with the non-Trp containing peptide 6 (δHα (Pro) = 4.47 ppm 
and δHβ (Pro) = 2.25 and 1.92 ppm). To support the NMR 
analysis, molecular dynamics (MD) simulations of peptide 7 
were conducted. 
 
Table 1. Summary of NMR data and Xaa-D-Pro bond conformation of peptides 3, 6, 7, 11, 16, 17, 18 and 23. b.s. means broad signal. 
Peptide Sequence c(Xaa-D-Pro-Yaa)2 
ΔδCβγ Xaa-D-Pro 
bond (ppm) 
Xaa-D-Pro bond 
conformation 
-ΔδNH/ΔT 
(ppb/K) 
3JNHHα (Hz) 
Xaa Yaa Xaa Yaa 
3 c(Arg-D-Pro-Trp)2 3.8 trans/trans 4.5 8.5 8.5 b.s. 
6 c(Glu-D-Pro-Ile)2 4.2 trans/trans 3.5 9.0 9.0 8.2  
7 c(Glu-D-Pro-Trp)2 3.7 trans/trans 1.5 8.1 8.1 7.7  
11 c(Ser-D-Pro-Trp)2 3.6 trans/trans 1.0 8.7 8.7 7.7  
16 c(Trp-D-Pro-Arg)2 4.1 trans/trans 2.8 9.6 9.6 b.s.  
17 c(Glu-D-Pro-D-Trp)2 5.8 trans/trans 8.7 2.7 5.3 7.7 
18 c(D-Glu-D-Pro-Trp)2 10.2 cis/cis 5.0 7.4 7.4 6.5 
  3.1 trans/trans 8.0 8.6 8.6 6.4 
23 c(D-Trp-D-Pro-Glu)2 9.6 cis/cis 7.0 6.6 6.6 6.8 
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In perfect agreement with the experimental results, the 
conformers obtained by replica exchange molecular dynamics 
(REMD) suggested a well-defined C2 symmetric conformation 
with two fused type II’ β turns, with D-Pro occupying the i+1 
position, and hydrogen bonds between the i and i+3 positions 
(Figure S3). The REMD-derived Ramachandran plots for these 
peptides (Figure S4) correlate with those of a β II’ turn (Φ (i+1) 
= 60o, Ψ (i+1) = -120o; Φ (i+2) = -80o, Ψ (i+2) = 0o).[19] Also 
consistent with the NMR results, the REMD simulations of 
peptide 7 indicated that the side chain χ1 dihedral angle 
samples a major population (Figure S5a) corresponding to 
the gauche (-) rotamer (χ1 ~ -60o).[20] The spatial proximity 
between the Trp and Pro side chains also pointed to the 
occurrence of CH-π interactions (Figure S5b). 
In the case of peptide 3 (c(Arg-D-Pro-Trp)2), NMR and 
REMD analysis indicated that the Trp side chains appeared to 
have different rotameric preferences. This peptide displayed a 
significant difference in 3JHαHβ values for the Hβ (Trp) protons 
(5.3 and 8.3 Hz) but a smaller diastereotopic splitting of these 
methylene protons (3.42 and 3.30 ppm) than peptides 7 and 
11 (Figure 2). Moreover, in peptide 3 both Hβ (Trp) protons 
exhibited NH–Hβ intra-residue NOE cross-peaks of similar 
intensity (Figure 1c). 
Analysis of the REMD simulations confirmed that, like 
peptide 7, peptide 3 adopts a C2 symmetric conformation with 
two fused type II’ b-turns (Figure S3). However, the Trp side 
chain of peptide 3 sampled two similarly populated rotameric 
states with χ1 values around 60 and -60o (Figure S5c) 
corresponding to the gauche (+) and gauche (-) rotamers, 
respectively (Figure 1d and 1e).[20] The smaller diastereotopic 
splitting of the Hβ (Trp) protons and closer 3JHαHβ values for 
peptide 3 when compared with peptide 7 are likely to be the 
effect of the conformational average of the two different Trp 
rotamers observed for 3. Furthermore, the most populated 
rotamer, gauche (+), would place the Trp and Arg side chains 
fairly close, thereby suggesting the presence of cation-π 
interactions that may fix the Trp side chain (Figure S5d). 
To assess the influence of the position of the aromatic 
residue on Trp side chain interactions, we examined peptide 
16 (c(Trp-D-Pro-Arg)2), in which the Trp residue precedes the 
D-Pro. The 3JNHHα values, temperature coefficients of the amide 
protons and the ΔδCβγ (D-Pro) values (Table 1) suggested that 
peptide 16 also adopts a conformation with two type II’ β-turns, 
similar to that previously described for peptides 3, 6, 7 and 11.  
However, peptide 16 did not show evidence of restricted 
rotation of the Trp side chain. The two Hβ (Trp) protons 
displayed similar chemical shifts (δHβ = 3.31 and 3.26 ppm) and 
3JHαHβ values (~ 7.5 Hz), which suggest rapid flipping of the 
aromatic side chain, thereby indicating the presence of distinct 
rotamers in fast exchange in the NMR time-scale. 
In addition, the chemical shifts of the D-Pro protons did not 
appear to be affected by the aromatic ring (δHα = 4.27 ppm; δHβ 
= 2.03 and 1.80 ppm). This observation supports the notion of 
the absence of strong Trp/Pro intramolecular interactions. In 
conclusion, cyclic hexapeptides of the type c(Xaa-D-Pro-Yaa)2 
adopt a C2 symmetric all-trans conformation with two fused 
type II’ β-turns. When D-Pro is followed by a Trp residue, the 
aromatic side chain seems to participate in structure-stabilizing 
intramolecular interactions, either with the preceding Pro (CH-
π interactions) or with the following Arg (cation-π), resulting in 
the predominance of specific Trp rotamers. 
Influence of the chirality of amino acids on the 
conformation of c(Xaa-D-Pro-Yaa)2 cyclic hexapeptides. To 
examine how the stereochemistry of each position on the 
repeated tripeptide motif present in this family of cyclic 
hexapeptides affects the conformational behavior of the cycle, 
all possible heterochiral stereoisomers of peptide 7 (c(Glu-D-
Pro-Trp)2) were synthesized (peptides 17, 18 and 29-31) 
(Scheme 1). Nonetheless, it was not possible to obtain the all-
L (c(Glu-Pro-Trp)2 and all-D c(D-Glu-D-Pro-D-Trp)2) homochiral 
stereoisomers as hexapeptides. Instead, during the cyclization, 
the formation of the corresponding cyclic homochiral 
dodecapeptides (c(Glu-Pro-Trp)4 and c(D-Glu-D-Pro-D-Trp)4) 
was only observed. Peptides 29 (DLD chirality), 30 (DLL 
chirality) and 31 (LLD chirality) are the enantiomeric sequences 
of peptides 7 (LDL chirality), 17 (LDD chirality) and 18 (DDL 
chirality), respectively, as confirmed both by CD (Figure S6), 
and NMR (Figure S7). 
Therefore, an NMR-based conformational analysis of 
peptides 17 (LDD chirality) and 18 (DDL chirality) was 
conducted and the results were compared with those of peptide 
7 (LDL chirality). A complete resonance assignment for these 
peptides is provided in the Supporting Information (Table S3). 
As expected, peptide 17 (c(Glu-D-Pro-D-Trp)2) showed C2 
symmetry in the NMR time-scale. The ∆δCβγ (D-Pro) value 
obtained for this peptide (∆δCβγ = 5.8 ppm) indicates prolyl 
imide bonds in trans configuration. Peptides 17 (LDD chirality) 
and 7 (LDL chirality) showed an opposite NH orientation. In 
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peptide 7, the amide NH proton of Pro-preceding L-Glu 
residues showed upfield chemical shifts (δNH = 7.70 ppm) and 
seemed to be solvent-protected (-ΔδNH/ΔT = 1.5 ppb K-1), 
whereas the amide NH proton of Pro-following L-Trp residues 
resonates at 8.48 ppm and are solvent-exposed (-ΔδNH/ΔT = 
8.1 ppb K-1). In peptide 17, in contrast, while the amide NH 
proton of Pro-following D-Trp residues displayed upfield 
chemical shifts (7.24 ppm) and appeared to be H-bonded (-
ΔδNH/ΔT = 2.7 ppb K-1), the Pro-preceding L-Glu residues (δNH 
= 8.20 ppm) displayed values (-ΔδNH/ΔT = 8.7 ppb K-1) typical 
of solvent-exposed amides (Table 1). This change in H-
bonding with respect to peptide 7 also implies a shift of the D-
Pro position in the β-turn. Assuming that D-Trp residues of 
peptide 17 are H-bonded and occupy the i position of the β-
turn, the D-Pro would be found in the i+2 position. D-Pro 
restricts the backbone dihedral angle φ to 60 ± 20º.[21]  This 
range of values for the φ (i+2) dihedral is possible only in the 
type II β-turn suggesting that peptide 17 has a high population 
of this β-turn type in solution.  
Comparing the NMR spectra of peptide 17 (LDD chirality) 
and 7 (LDL chirality), a general observation emerges, namely 
that the former peptide displays higher conformational flexibility. 
As an example, the chemical shift difference ∆δCβγ (D-Pro) of 
peptide 17 (∆δCβγ = 5.8 ppm) was slightly larger than that of 
peptide 7 (∆δCβγ (D-Pro) = 3.6 ppm), thereby suggesting an 
increased flexibility of proline rings in peptide 17. A further 
suggestion of the dynamic nature of peptide 17 is the 
observation that the chemical shift of the Hd (Pro) proton 
resonating at 3.58 ppm was found to be temperature-
dependent (Figure S8). In the temperature range tested (278 
to 308 K), this behavior was detected only in peptide 17. The 
3JNHHα values for peptide 17 (5.3 and 7.7 Hz) were smaller than 
those observed for peptide 7 (8.1 and 7.8 Hz) (Table 1). 3JNHHα 
values around 6-7 Hz are indicative of the coexistence of 
rapidly interconverting conformers in solution.  
Another notable difference of peptide 17 (c(Glu-D-Pro-D-
Trp)2) with respect to peptides of the series c(Xaa-D-Pro-Trp)2 
is that the NMR spectra of peptide 17 did not show evidence of 
the predominance of any Trp rotamer. Similar Hβ (Trp) 
chemical shifts (3.29 and 3.21 ppm) and 3JHαHβ (Trp) values 
(7.2 and 7.0 Hz) were observed for the diastereotopic 
methylene Hβ (Trp) protons of this peptide (Figure 2).  
Unlike peptide 7, analysis of the REMD trajectories of 
peptide 17 suggested the occurrence of two predominant 
backbone conformations (Figure S9). Dihedral angles for Pro 
residues are around Φ = 60 ± 20o and Ψ = 0 ± 30o, indicating 
either type βI’ (canonical dihedral values Φ (i+1) = 60o, Ψ (i+1) 
= 30o)[19] or type βII (canonical dihedral angles Φ (i+2) = 80o, Ψ 
(i+2) = 0o).[19] If type I’ β-turns with D-Pro in the i+1 position 
were present in the structural ensemble of peptide 17, the i+2 
position would be occupied by D-Trp residues displaying 
typical βI’ dihedral angles (Φ (i+2) = 90o, Ψ (i+2) =0o). These 
values perfectly correlate with the most populated region 
observed in the Ramachandran plot of D-Trp (Figure S10). In 
the case of type II β-turns, Glu residues would occupy i+1 
positions, presenting typical II β-turn dihedral angles (Φ (i+1) = 
-60o, Ψ (i+1) = 120o), which are in agreement with one of the 
regions sampled by Glu residues in the Ramachandran plot. 
These observations may indicate that the conformational 
flexibility of peptide 17 suggested by NMR is most likely the 
result of a fast interconversion process, on the NMR time scale, 
between type II and type I’ β-turn populations. On the basis of 
metadynamics simulations, a possible mechanism for this type 
I’ ↔ II inter-conversions in cyclic hexapeptides was recently 
reported by McHugh et al.[22] The authors proposed a pathway 
that involves a shift of the β-turn locations. The i+2 residues of 
the initial β-turn assume the i+1 positions of β-turns in the final 
conformation via coupled two-dihedral changes.  
NMR analysis of peptide 18 (c(D-Glu-D-Pro-Trp)2) was 
complicated since it presented various conformers in slow 
exchange in the NMR time-scale (Figure 3). Remarkably, the 
major species (85% at 298 K) corresponded to the C2 
symmetric two-cis D-Glu-D-Pro conformer, as deduced from 
the ∆δCβγ (D-Pro) value (∆δCβγ = 10.2 ppm). The C2 symmetric 
all-trans conformer was also identified on the basis of the ∆δCβγ 
(D-Pro) value (∆δCβγ = 3.1 ppm). A subset of minor NMR 
signals coexisting with those of the two major species was also 
observed but they could not be assigned due to their lower 
intensity and to severe spectral overlap. A recent study[23] 
reported that a peptide with the enantiomeric chirality of 
peptide 18, c(Ser-Pro-D-Phe-Lys-Pro-D-Phe), adopts a 
conformation with two pseudo-type VIb β-turns. This type VIb 
β-turn is characterized by cis proline in position i+2 and no 
intramolecular hydrogen bonds. These features are in 
agreement with the NMR experimental data obtained for 
peptide 18 (Table 1). Analysis of the REMD simulations of the 
major conformer of peptide 18 (two-cis D-Glu-D-Pro bonds) 
supported the presence of βVIb-like turns. 
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Figure 3. Expanded regions of the TOCSY spectra of peptide 18 showing 
the presence of different spin systems for Glu (a) and Trp (b) residues 
corresponding to the trans/trans (~ 15%) and cis/cis (~ 85%) conformations 
observed for this peptide.  
Thus, as expected for this type of turn, no hydrogen bonds 
were observed in the most populated states of the trajectory 
(Figure S11). Most importantly, the REMD-derived 
Ramachandran plots (Figure S12) displayed values 
characteristic of the enantiomer of a βVIb-like turn with D-Glu 
residues in the i+1 position (Φ = 135o, Ψ = -135o) and D-Pro in 
the i+2 position (Φ = 75o, Ψ = -160o). A surprising observation, 
however, is that distinct Ramachandran plots were obtained for 
the same type of residue, for example between the two D-Pro 
residues. One of the D-Pro residues sampled a region 
corresponding to Φ = 60o, Ψ = 0o, which may point to the 
presence of pseudo-βVIa2 turns. These observations may 
indicate the presence of non-symmetric conformations, which 
may correspond to the minor species detected in the 1H NMR 
spectrum of this peptide.  
Study of the cis content of peptides of the type (D-Xaa-D-Pro-
Yaa)2 
The cis Xaa-Pro segment of type VI β-turns has been proposed 
as a potential binding motif for various peptidyl prolyl cis/trans 
isomerases (PPIases), which are emerging as important 
biomedical targets related with diseases such as cancer, 
Alzheimer’s disease, and asthma.[24] Given that peptide 18 
(DDL chirality) seemed to adopt, at least to some extent, a 
double βVIb-like structure, we performed several modifications 
on this peptide to assess the influence of the Pro-preceding 
and Pro-following positions on the configuration of the D-Xaa-
D-Pro bond. First, the Xaa and Yaa positions of peptide 18 
were individually (peptides 19 and 20) and simultaneously 
(peptide 21) (Scheme 1) replaced by Ala while retaining the 
configuration of the parent compound. The Trp residues were 
then replaced for Tyr (peptide 22) (Scheme 1) to compare the 
effects of different aromatic residues in the Yaa position. A 
complete resonance assignment for these peptides is provided 
in the Supporting Information (Table S4 and Figure S13).  
The NMR-derived populations of conformers at 298 K are 
shown in Table 2. Removal of the aromatic side chain of the 
Yaa position reduced the cis/cis content from 85% in peptide 
18 to 60% in peptide 20. More interestingly, when the Xaa and 
Yaa residues were simultaneously replaced by Ala (peptide 21), 
the cis/cis content was drastically reduced to < 5%. No 
significant changes on cis/cis content were observed between 
peptides 18 (Yaa = Trp) and 22 (Yaa = Tyr). These results 
indicate that the cis D-Xaa-D-Pro bond is favored when the D-
Pro residue is followed by aromatic amino acids. However, the 
nature of the amino acid placed in the Xaa position also affects 
the conformation of the D-Xaa-D-Pro bond.  
Next, we synthesized four cyclic hexapeptides containing 
a D-Trp-D-Pro motif followed by a variable Yaa position 
(peptides 23-26) (Scheme 1 and Table S5). All the evaluated 
peptides, irrespective of the chemical nature of the Yaa residue 
(23, Yaa = Glu; 25, Yaa = Arg; and 26, Yaa = Gln) exhibited a 
D-Xaa-D-Pro bond cis/cis content in excess of 95% (Table 2 
and Figure S14). Of particular interest is the comparison 
between peptides 23 (c(D-Trp-D-Pro-Glu)2) and 18 (c(D-Glu-D-
Pro-Trp)2), in which the nature of the residues on Xaa and Yaa 
positions were switched. Remarkably, the cis/cis content 
increased from 85% in peptide 18 to > 95% in peptide 23, 
thereby demonstrating that the tendency of aromatic residues 
to favor cis D-Xaa-D-Pro bonds increases when they precede 
D-Pro residues. This observation is in agreement with a 
previous report that proposed that aromatic side chains 
preceding D-Pro residues tend to favor the cis conformation of 
amide bonds.[25]  
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Table 2. Cis/cis content at 298 K of the D-Xaa-D-Pro bonds in peptides 19-
23.  
Peptide  Sequence cis/cis content[c] 
Other 
conformers 
detected 
18 c(D-Glu-D-Pro-Trp) ~ 85% trans/trans 
19[a] c(D-Ala-D-Pro-Trp)2 -- -- 
20 c(D-Glu-D-Pro-Ala)2 ~ 60% trans/trans 
21 c(D-Ala-D-Pro-Ala)2 < 5% trans/trans 
22 c(D-Glu-D-Pro-Tyr)2 ~ 90% trans/trans 
23[b] c(D-Trp-D-Pro-Glu)2 > 95% -- 
24[a] c(D-Trp-D-Pro-Ala)2 -- -- 
25[b] c(D-Trp-D-Pro-Arg)2 > 95% -- 
26[b] c(D-Trp-D-Pro-Gln)2 > 95% -- 
27 c(D-Ile-D-Pro-Glu)2 ~ 80% cis/trans 
28 c(D-Ala-D-Pro-Glu)2 ~ 10% trans/trans 
[a] Peptides 19 and 24 could not be evaluated due to solubility restrictions.  
[b] Minor conformation could not be unambiguously assigned due to very 
low signal intensity.  
[c] Quantification was done by peak integration in 1D 1H-NMR spectra. More 
precise quantification could not be performed due to signal overlap. 
To further analyze the influence of the aromatic side chain 
in the Pro-preceding position, we compared the cis/cis content 
of peptide 23 (c(D-Trp-D-Pro-Glu)2) with two additional 
peptides in which the D-Trp was replaced by D-Ile (peptide 27) 
and by D-Ala (peptide 28) (Table S5).  
Removal of the aromatic side chain decreased the cis/cis 
content in both cyclic hexapeptides (Table 2). Replacement of 
the aromatic residue by Ala had a drastic effect. In peptide 28 
we observed only 10% of the two-cis conformer, the all-trans 
being the most abundant. However, when the aromatic residue 
was substituted by a bulky side chain, such as Ile (peptide 27), 
only a moderate decrease in the cis/cis content (from > 95% to 
80%) was observed. These findings suggest that the cis 
configuration of the amide bond in D-Xaa-D-Pro motifs is 
favored to minimize steric effects when bulky side chains 
precede the D-Pro residue.  
The major difference in the NMR behavior of peptides 18 
c(D-Glu-D-Pro-Trp)2 and 23 c(D-Trp-D-Pro-Glu)2 is that the 
latter exhibited restricted rotation of the aromatic side chains, 
as deduced from the 1Hβ chemical shifts (3.39 and 3.03 ppm) 
(Figure 2) and 3JHαHβ coupling constants (4.4 and 10.9 Hz) of 
Trp residues. The Hα (Pro) proton of peptide 23 (δHα = 3.43 
ppm) showed the largest upfield shift of all the peptides 
described in this work, which may provide indirect evidence of 
intramolecular CH-π interactions.  
The observation of NOE crosspeaks of similar intensities 
between NH (Trp) – Hβ1/Hβ2 (Trp) (Figure 4) suggested the 
presence of a major trans rotamer for this side chain. The 
same behavior was observed for peptides 25 and 26, as 
reflected by the observed diastereotopic splitting of Hβ (Trp) 
protons (δHβ = 3.38, 3.01 ppm, and 3.40, 3.05 ppm for peptides 
25, and 26, respectively), the 3JHαHβ (Trp) coupling constants 
(3JHαHβ = 4.8 and 10.4 Hz in both peptides) and the upfield shift 
on the Hα (Pro) protons (δHα = 3.48 and 3.45 ppm for peptides 
25, and 26, respectively).  
 
Figure 4. a) Selected region of the NOESY spectrum of peptide 23 showing 
intra-residue NOE correlation for the Trp residues of the trans conformer. 
Both Hβ protons exhibited NH-Hβ intra-residue NOE cross-peaks of similar 
intensity. b) Representation of the Newman projection of the trans rotamer. 
c) Histogram representation of the values sampled by the χ1 dihedral angle 
in the REMD simulation for peptide 23; and d) Schematic representation 
showing CH-π interactions between the side chains of proline and 
tryptophan in peptide 23. 
The REMD simulations of peptide 23 point to a βVIb-like 
conformation similar to that of peptide 18. Again, no 
intramolecular hydrogen bonds were observed during the MD 
trajectory of peptide 23 (Figure S15). The D-Pro residue, which 
would be in the i+2 position of these β-turns, sampled the 
region corresponding to Φ = 75o, Ψ = -160o, which is exactly 
the mirror image of those described for βVIb-turns (Φ= -75o, 
Ψ= 160o)[17]. D-Trp residues sampled the region corresponding 
to Φ = 150o, Ψ = -150o, which are close to the canonical values 
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(Φ = -135o, Ψ = 135o)[17] described for residue i+1 of βVIb turns 
(Figure S16).  
Interestingly, REMD showed a major population sampling 
a Trp side chain χ1 ~ 180o (Figure 4c) that perfectly correlates 
with the trans rotamer suggested by the experimental results. 
This rotamer would place the Trp and Pro side chains in close 
proximity (Figure 4d). Such proximity may explain the unusual 
chemical shifts of the Pro proton resonances caused by the 
presence of CH-π interactions, which may stabilize the whole 
conformation of this peptide.  
A summary of the results obtained for the most 
representative peptides is shown in Table 3. We have 
demonstrated the feasibility of tuning the conformation of cyclic 
hexapeptide scaffolds of the type c(Xaa-D-Pro-Yaa)2. This is 
achieved by changing the chemical nature and 
stereochemistry of the amino acids in positions Xaa and Yaa. 
Conclusions 
Here we show how the chemical nature and/or stereochemistry 
of the amino acids in cyclic hexapeptide scaffolds can 
modulate the conformational preferences of the backbone. By 
changing these two properties, we were able to obtain various 
b-turn-like conformations that may be useful in the field of 
molecular recognition. Moreover, we reveal that the chemical 
nature and the stereochemistry of the amino acids present in 
this kind of cyclic peptide also affects the orientation of side 
chains, affording distinct types of stabilizing contacts between 
side chains, such as CH-p or cation-p interactions. REMD 
simulations were able to overcome the multiple energy barriers  
that are needed to be surmounted to sample the diverse 
conformational states of cyclic hexapeptides in solution. This 
in silico approach also allowed us to analyze the Trp side chain 
c1 angles of the studied peptides to predict possible 
interactions between side chains. Our results contribute to the 
further development of constrained cyclic peptides for 
molecular recognition processes. Moreover, they pave the way 
to create a skeletal conformational diversity, which is of great 
interest in the recognition of challenging protein surfaces. 
 
Supporting Information Summary 
Experimental methods, a detailed MS, CD and NMR 
characterization of peptides, and structural models and RMED 
analysis of selected cyclic hexapeptides are provided in the 
Supporting Information. 
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Table 3. Summary of the conformational preferences of a representative set of peptides.  
Peptide  Sequence  c(Xaa-D-Pro-Yaa)2 
Xaa-D-Pro 
bond major 
conformation 
b-turn 
type like 
Trp side chain 
Rotation Intramolecular interactions Major rotamer 
3 c(Arg-D-Pro-Trp)2 trans/trans II’ restricted cation-π gauche (+) / gauche (-) 
7 c(Glu-D-Pro-Trp)2 trans/trans II’ restricted CH-π gauche (+) 
16 c(Trp-D-Pro-Arg)2 trans/trans II’ free ---- --- 
17 c(Glu-D-Pro-D-Trp)2 trans/trans II’/ I’ free ---- --- 
18  c(D-Glu-D-Pro-Trp)2 cis/cis (~ 85%) VIb free ---- --- 
23 c(D-Trp-D-Pro-Glu)2 cis/cis (> 95%) VIb restricted CH-π trans 
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hexapeptides: we have found 
that conformational diversity in 
symmetric cyclic hexapeptides 
can be modulated by changing 
the chemical nature and 
stereochemistry of their residues. 
Using NMR and MD, we have 
extensively analysed the 
conformational preferences of a 
family of cyclic hexapeptides.  
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